JP2012530057A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530057A5
JP2012530057A5 JP2012515147A JP2012515147A JP2012530057A5 JP 2012530057 A5 JP2012530057 A5 JP 2012530057A5 JP 2012515147 A JP2012515147 A JP 2012515147A JP 2012515147 A JP2012515147 A JP 2012515147A JP 2012530057 A5 JP2012530057 A5 JP 2012530057A5
Authority
JP
Japan
Prior art keywords
agent
drug
peptide
administered
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012515147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530057A (ja
JP6005514B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/038200 external-priority patent/WO2010144721A2/en
Publication of JP2012530057A publication Critical patent/JP2012530057A/ja
Publication of JP2012530057A5 publication Critical patent/JP2012530057A5/ja
Application granted granted Critical
Publication of JP6005514B2 publication Critical patent/JP6005514B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012515147A 2009-06-10 2010-06-10 神経疾患の治療のためのモデル系及び治療計画 Expired - Fee Related JP6005514B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18598909P 2009-06-10 2009-06-10
US61/185,989 2009-06-10
PCT/US2010/038200 WO2010144721A2 (en) 2009-06-10 2010-06-10 Model systems and treatment regimes for treatment of neurological disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015214926A Division JP6220371B2 (ja) 2009-06-10 2015-10-30 神経疾患の治療のためのモデル系及び治療計画

Publications (3)

Publication Number Publication Date
JP2012530057A JP2012530057A (ja) 2012-11-29
JP2012530057A5 true JP2012530057A5 (cg-RX-API-DMAC7.html) 2013-07-04
JP6005514B2 JP6005514B2 (ja) 2016-10-12

Family

ID=43309469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012515147A Expired - Fee Related JP6005514B2 (ja) 2009-06-10 2010-06-10 神経疾患の治療のためのモデル系及び治療計画
JP2015214926A Expired - Fee Related JP6220371B2 (ja) 2009-06-10 2015-10-30 神経疾患の治療のためのモデル系及び治療計画

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015214926A Expired - Fee Related JP6220371B2 (ja) 2009-06-10 2015-10-30 神経疾患の治療のためのモデル系及び治療計画

Country Status (14)

Country Link
US (2) US8940699B2 (cg-RX-API-DMAC7.html)
EP (2) EP3808366A1 (cg-RX-API-DMAC7.html)
JP (2) JP6005514B2 (cg-RX-API-DMAC7.html)
CN (1) CN102458441A (cg-RX-API-DMAC7.html)
AU (1) AU2010258664B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1010718A2 (cg-RX-API-DMAC7.html)
CA (1) CA2765169C (cg-RX-API-DMAC7.html)
DK (1) DK2440230T3 (cg-RX-API-DMAC7.html)
ES (1) ES2847293T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20210112T1 (cg-RX-API-DMAC7.html)
HU (1) HUE053131T2 (cg-RX-API-DMAC7.html)
PL (1) PL2440230T3 (cg-RX-API-DMAC7.html)
PT (1) PT2440230T (cg-RX-API-DMAC7.html)
WO (1) WO2010144721A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510824B2 (en) * 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
CA2765169C (en) 2009-06-10 2019-06-18 Nono Inc. Model systems and treatment regimes for treatment of neurological disease
US9629892B2 (en) 2010-08-12 2017-04-25 Nono Inc. Treatment of penetrative injury to the brain
HRP20220519T1 (hr) 2011-06-24 2022-05-27 Nono Inc. Kombinacijska terapija ishemije
AU2012354072B2 (en) * 2011-12-13 2017-04-27 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
US9241970B2 (en) 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
AU2013204309A1 (en) * 2012-11-13 2014-05-29 Biodiem Limited Therapeutic Compounds and Uses Thereof
TR201905787T4 (tr) * 2012-11-28 2019-05-21 Nono Inc Liyofilize TAT-NR2B9C formülasyonu.
US10251935B2 (en) 2012-11-28 2019-04-09 Nono Inc. Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose
UA123820C2 (uk) * 2014-05-28 2021-06-09 Ноно Інк. Хлоридна сіль пептиду tat-nr2b9c
US20190134150A1 (en) * 2016-04-27 2019-05-09 Biocells (Beijing) Biotech Co., Ltd. Therapeutic methods for excitatory neurotoxicity-related injuries
US11229675B2 (en) 2016-04-27 2022-01-25 Biocells (Beijing) Biotech Co., Ltd. Therapeutic peptides for excitatory neurotoxicity-related injuries
CN110049994B (zh) * 2016-12-08 2023-05-02 拜西欧斯(北京)生物技术有限公司 一种缀合物及其应用
KR102403089B1 (ko) * 2017-07-05 2022-06-02 바이오셀즈(베이징) 바이오테크 코., 엘티디. 폴리펩타이드의 약학적으로 허용 가능한 염 및 이의 용도
CN110799547B (zh) * 2017-07-05 2023-02-28 拜西欧斯(北京)生物技术有限公司 用于治疗、改善或预防神经系统相关病症的化合物及其用途
EP3693001A4 (en) 2017-09-30 2021-07-07 Biocells (Beijing) Biotech Co., Ltd. PEPTIDIC COMPOSITION ALLOWING THE TREATMENT OF INJURIES RELATED TO EXCITING NEUROTOXICITY
CN113121641B (zh) 2021-03-11 2022-11-01 武汉英纳氏药业有限公司 一类多功能多肽及其在医药领域的应用
CN113150065B (zh) 2021-03-11 2022-07-08 武汉英纳氏药业有限公司 一种合成肽及其应用
CN113735938B (zh) * 2021-07-30 2024-11-08 英纳氏(珠海)药业有限公司 一种神经保护多肽化合物及其应用
CN114642402A (zh) * 2022-03-07 2022-06-21 翰博瑞强(上海)医药科技有限公司 一种用于预测药物对心脏毒性影响的方法及心电图设备
CN114469084B (zh) * 2022-04-02 2022-06-24 剑博微电子(深圳)有限公司 一种基于高精度adc的血氧监测系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060148711A1 (en) 1999-05-14 2006-07-06 Arbor Vita Corporation Molecular interactions in neurons
US7510824B2 (en) 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
GB0025473D0 (en) 2000-10-17 2000-11-29 Pfizer Ltd Pharmaceutical combinations
CA2505479A1 (en) * 2002-11-14 2004-06-03 Arbor Vita Corporation Molecular interactions in neurons
WO2004071531A1 (en) 2003-02-13 2004-08-26 Licentia Oy Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
BRPI0409865A (pt) 2003-05-02 2006-05-16 Paion Deutschland Gmbh injeção intravenosa de ativadores de plasminogênio não neurotóxicos para o tratamento do ataque de apoplexia
CA2657665C (en) * 2006-07-11 2015-06-02 Arbor Vita Corporation Method and compositions for treating stroke with fever
EP1884521A1 (en) * 2006-07-31 2008-02-06 Xigen S.A. Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
ES2446292T3 (es) * 2007-03-02 2014-03-07 Nono Inc. Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N
WO2009006611A1 (en) 2007-07-03 2009-01-08 Arbor Vita Corporation Small molecule inhibitors of pdz interactions
US8080518B2 (en) 2007-12-05 2011-12-20 Arbor Vita Corporation Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
PL2320927T3 (pl) 2008-07-09 2016-02-29 Univ Copenhagen Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD
CA2765169C (en) 2009-06-10 2019-06-18 Nono Inc. Model systems and treatment regimes for treatment of neurological disease
HRP20220519T1 (hr) 2011-06-24 2022-05-27 Nono Inc. Kombinacijska terapija ishemije
US9241970B2 (en) 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
AU2012354072B2 (en) 2011-12-13 2017-04-27 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia

Similar Documents

Publication Publication Date Title
HRP20210112T1 (hr) Režimi liječenja namijenjeni liječenju neurološke bolesti
JP7085457B2 (ja) 虚血のための組み合わせ療法
US11737810B2 (en) Immunotherapeutic methods using electroporation
US20240008911A1 (en) Immunotherapeutic methods using electroporation
Prunier et al. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial
JP2015501834A5 (cg-RX-API-DMAC7.html)
Gigliucci et al. Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression
Chaparro-Cabanillas et al. Transient middle cerebral artery occlusion model of stroke
CA2951686C (en) The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenesis in a subject
AU2021206472A1 (en) Plasmin-resistant peptides for treating stroke and related conditions
Wu et al. Combined VEGF and bFGF loaded nanofiber membrane protects against neuronal injury and hypomyelination in a rat model of chronic cerebral hypoperfusion
Choovongkomol et al. Effect of a single-dose dexmedetomidine on postoperative delirium and intraoperative hemodynamic outcomes in elderly hip surgery; A randomized controlled trial dexmedetomidine for postoperative delirium: dexmedetomidine for postoperative delirium
Tanabe et al. Preliminary study on safe thresholds for temporary internal carotid artery occlusion in aneurysm surgery based on motor-evoked potential monitoring
Boulos et al. Tamoxifen as an effective neuroprotectant in an endovascular canine model of stroke
Wróbel et al. The influence of nebivolol on the activity of BRL 37344—the β3‐adrenergic receptor agonist, in the animal model of detrusor overactivity
WO2015190989A1 (en) The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
WO2025092750A1 (zh) (3-氨基-5-乙基金刚烷-1-基)硝酸甲酯及其药学上可接受的盐的医药用途
Vichaya et al. Spinal glia modulate both adaptive and pathological processes
JP6351639B2 (ja) リンパ節検出のための低浸透圧溶液
Tamura et al. Endovascular embolization of brain arteriovenous malformations with Eudragit-E
Shabani et al. Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
Zheng et al. The novel PSD-95 inhibitor BXOS110 provides neuroprotection in acute ischemic stroke
Ravikumar et al. Pilot randomised control trial: neuromuscular electrical stimulation in treating venous disease
Rajendran et al. Hypertension: Interventional Options
Xiao-jun Endovascular embolic treatment of ruptured vertebral artery dissecting aneurysms